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a b s t r a c t
Current classiﬁcation of primary progressive aphasia (PPA) encompasses three variants:
non-ﬂuent (nfvPPA), semantic (svPPA) and logopenic (lvPPA). Previously lvPPA was regarded
as aphasic form of Alzheimer's disease (AD). However, not all patients with lvPPA phenotype
present with AD pathology. Despite abundant literature on differentiation of lvPPA from
svPPA and nfvPPA, studies comparing lvPPA with AD and mild cognitive impairment (MCI)
are scarce. This study aimed at analyzing written descriptive output in lvPPA, AD and MCI.
Thirty-ﬁve patients participated in the study: 9 with lvPPA, 13 with AD and 13 with MCI. Most
aspects of writing performance were comparable in three groups. However, letter insertion
errors appeared in 44% patients with lvPPA, while they were absent in AD and MCI. Patients
with lvPPA used more verbs than patients with AD. Writing proﬁle may complement other
neuropsychological assessment results in the differential diagnosis of lvPPA. Letter insertion
errors and frequent verb use may raise a query of lvPPA.
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Primary progressive aphasia (PPA) is currently regarded as a
spectrum of progressive language disorders due to either
frontotemporal lobar degeneration (FTLD) or Alzheimer's
disease (AD). The most recent PPA subdivision encompasses
its three variants: non-ﬂuent (nfvPPA), semantic (svPPA) and
logopenic (lvPPA) [1,2]. The last, logopenic variant, described
formally in 2004 by Gorno-Tempini et al. [3] was previously
regarded as language variant of AD [4]. Logopenic progressive
aphasia is characterized by word-ﬁnding difﬁculties (with
preserved semantic knowledge and word comprehension),
impaired phonological processing and short verbal span
causing deﬁcient repetition and comprehension of long
sentences [5–9].
While svPPA has a clinically distinct proﬁle, with general-
ized semantic impairment and circumscribed temporal pole
atrophy, the differentiation of lvPPA from nfvPPA remains
challenging in the clinic [1,10–12], especially in patients with
more advanced disease. In the research setting beta-amyloid
imaging and cerebrospinal ﬂuid biomarkers proﬁle assess-
ment are very useful for the differential diagnosis between AD
and FTLD pathology [13]. However, their availability is very
limited. Moreover, a subset of patients with lvPPA has negative
beta-amyloid imaging [14]. Thus, the diagnosis of lvPPA is
established mainly on the basis of the clinical presentation
and longitudinal observation. Patients with lvPPA show rapid
and wide-spread cognitive deterioration [7,15,16] and decline
in the activities of daily living [17]. Several algorithms have
been proposed to differentiate between three variants of PPA
[18–20]. However, in the clinical practice lvPPA needs to be
differentiated not only from nfvPPA and svPPA, but also from
AD and mild cognitive impairment. This differentiation is
important for planning patient management, as patients with
lvPPA require more frequent neuropsychological follow-ups
and language intervention.
Thus, neuropsychological assessment is crucial for early
differential diagnosis. Magnin et al. [21] has recently shown
that lvPPA (in comparison to AD and MCI) is characterized by
a recent onset or aggravation of anxiety, preserved orientation
to time, poor verbal span and ﬂuency, dissociation between
poor verbal memory performance and much better visual
memory performance as well as very impaired mental
calculation. This is to our knowledge, the only paper
addressing the neuropsychological differential diagnosis of
lvPPA from MCI and AD.
Agraphia in the context of AD is quite well described in the
literature [22] and written output is more sensitive than
spoken output to early language problems in AD [23]. In the
course of AD initial lexical dysgraphia (that affects spelling
of irregular words) progresses to phonological agraphia (that
affects also spelling of regular words due to graphemic buffer
impairment). Moreover, agraphia in AD is closely related to
cognitive impairment, mainly attentional and executive
deﬁcits [22], typical for the later disease stages. Writing
assessment in the context of AD spectrum differential
diagnosis may also be helpful to detect parkinsonian features
(more likely in nfvPPA than lvPPA) or spatial problems,
suggestive of posterior cortical atrophy.The current diagnostic criteria for PPA highlight the role
of writing assessment in the diagnosis of svPPA, which is
characterized by surface dysgraphia [1]. However, psycholin-
guistic assessment of spelling in patients with nfvPPA, lvPPA,
svPPA and unclassiﬁed PPA showed that spelling errors lack
variant speciﬁcity and all PPA patients, regardless of the PPA
variant, may present with impaired access to lexical or lexical-
semantic representations, impaired sublexical phonology-to-
ortography conversion and graphemic buffer impairment [24].
Most commonly, patients with lvPPA have lexical or surface
dysgraphia, but there are also reports of graphemic buffer
disorder [25].
Our study aimed at establishing the value of written picture
description in the differentiation of lvPPA from AD and MCI. It
was hypothesized that lexical content will be most impover-
ished in lvPPA, due to prominent word-ﬁnding difﬁculties.
Similarly, it was expected that spelling errors will be more
common in lvPPA than in AD and MCI, because of primary
phonological deﬁcit in lvPPA.
2. Materials and methods
2.1. Participants
Thirty-ﬁve patients participated in the study: nine (seven
women, two men) with the clinical diagnosis of lvPPA
according to Gorno-Tempini et al. criteria [1], 13 with mild
AD (seven women, six men) diagnosed according to the criteria
by McKhann [26], scoring 1 on Clinical Dementia Rating (CDR)
[27] and 13 patients with MCI (CDR = 0.5) (11 women, 2 men)
according to the criteria by Petersen [28]. Within the MCI group
eight patients had amnestic MCI and ﬁve multiple-domain
MCI (amnestic with attentional deﬁcits). The patients were
diagnosed in two centers specializing in the differential
diagnosis of neurodegenerative disorders. The groups were
matched in terms of years of education (see Table 1), sex
( p = 0.196) and time since onset ( p = 0.320). The lvPPA group
did not signiﬁcantly differ in age either from MCI or AD group.
The MCI group was signiﬁcantly younger than the AD group.
The median time since symptom onset was 2 years in both
lvPPA and AD and it ranged from 1 to 10 years in lvPPA and
from 1 to 6 years in AD. None of the patients reported the
history of developmental language problems (e.g. dyslexia or
dysgraphia). All participants volunteered for this study and
provided informed consent to participate. The study proce-
dures were approved by local Bioethics Committee.
2.2. Methods
To assess the patients' descriptive writing the untimed written
description of one of three pictures was administered: Cookie
theft picture from Boston Diagnostic Aphasia Examination-3
[29], picture from Frenchay Aphasia Screening test [30] or
A beach scene by Prof. EK Warrington [31]. The choice of
two pictures was due to the fact that most patients were
administered an oral picture description task few days before
the study procedure and the use of the same picture for a
written task was not considered appropriate. Written picture
description was administered by a neuropsychologist (EJS or
Table 1 – Demographic and clinical data in patients with logopenic progressive aphasia (LPA), Alzheimer's disease (AD) and
mild cognitive impairment (MCI).
LPA
n = 9
Mean (SD)
AD
n = 13
Mean (SD)
MCI
n = 13
Mean (SD)
pc Signiﬁcant intergroup differences
Age 70 (6) 77 (5) 67 (8) 0.002 AD vs. MCIa
Years of education 13 (3) 12 (4) 13 (3) 0.872 –
MMSE – 24.23 (2.55) 28.15 (1.41) <0.001 AD vs. MCI
Confrontation naming (% correct) 49 (23) 63 (23) 74 (17) 0.041 LPA vs. MCIa
Verbal ﬂuency
-Phonemic 8.44 (4.20) 9.69 (5.10) 12.04 (3.34) 0.158 –
-Semantic 11.56 (6.54) 11.31 (4.25) 18.15 (4.99) 0.003 LPA vs. MCIa; AD vs. MCIb
a p < 0.05.
b p < 0.01.
c The intergroup comparisons were performed with H Kruskal–Wallis test.
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independent raters specializing in speech pathology (KKK and
MK). The raters were blinded to the clinical diagnosis in each
patient. Divergent scores were discussed with the third rater
(EJS) and scores reported were reached by consensus. For each
assessed parameter raw scores (number of occurrence) were
used in the analysis: number of words, lexical content (number
of nouns and verbs), letter errors (omissions, additions,
substitutions and transpositions), syntactic structure param-
eters (number of sentences, complex sentences and correct
sentences, max. sentence length). Raters were also asked to
detect features suggestive of micrographia, the presence ofTable 2 – Comparison of descriptive writing in patients with lo
Alzheimer's disease (AD) and with mild cognitive impairment 
LPA
n = 9
AD
n = 13
Lexical content
Number of words (rs) 23.33 (7.19)a 19.00 (11.92) 
Nouns (rs) 10.44 (2.74) 9.69 (4.91) 
% of nouns 45.83 (7.14) 54.62 (19.40) 
Verbs (rs) 5.78 (1.79) 2.85 (2.19) 
% of verbs 26 (17–29) 17.88 (20.10) 
Spelling errors
Deletions (rs) 0 (0–5)b 1 (0–3) 
Insertions (rs) 0 (0–2) 0 
Substitutions (rs) 1 (0–4) 1 (0–4) 
Transpositions (rs) 0 0 
Letter errors – sum (rs) 1 (0–8) 2 (0–5) 
Sentence
Max. sentence length 9 (5–22) 6 (0–19) 
Sentences (rs) 3.89 (1.05) 2.08 (1.71) 
Complex sentences (rs) 1 (0–2) 0 (0–1) 
Correct sentences (rs) 2 (1–5) 1 (0–3) 
Script
Omission of diacritical marks
(n of cases/percentage)
Yes – 4 (44%) Yes – 10 (77%
No – 5 (56%) No – 3 (23%) 
Punctuation errors (n of cases/percentage) Yes – 8 (89%) Yes – 12 (92%
No – 1 (11%) No – 1 (8%) 
rs, raw score.
a Mean (SD).
b Median (range).
c Intergroup comparisons were performed with one-way ANOVA, its nonomission of diacritical marks, punctuation errors and the use
of mixed script (cursive and print). Subsequently, so as to make
the results of lexical analysis independent of the variable
sample length, percentage of nouns and verbs used was
computed.
Additionally, the patients were administered a confronta-
tion naming task (60-item Boston Naming Test, BNT [29];
30-item naming subtest from Sydney Language Battery [20],
15-item short version of BNT or 12-item Naming component
from Addenbrooke's Cognitive Examination-III [32]. As differ-
ent tests were used in two centers, the naming test results are
presented as percentage of correct answers. Moreover, thegopenic progressive aphasia (LPA) to patients with
(MCI).
MCI
n = 13
pc Signiﬁcant intergroup differences
25.77 (10.35) 0.255 –
11.85 (3.93) 0.407 –
47.58 (7.38) 0.248 –
4.23 (1.96) 0.008 LPA vs. AD
18 (0–30) 0.320 –
0 (0–2) 0.415 –
0 0.02 LPA vs. AD; LPA vs. MCI
0 (0–2) 0.240 –
0 (0–1) 0.429 –
1 (0–3) 0.180 –
9 (0–22) 0.138
2.85 (1.41) 0.025 LPA vs. AD
1 (0–2) 0.237 –
2 (0–5) 0.021 –
) Yes – 6 (46%) 0.191 –
No – 7 (54%)
) Yes – 11 (85%) 0.826 –
No – 2 (15%)
-parametric equivalent H Kruskal–Wallis test or chi-square test.
Table 3 – Profile of spelling errors in patients with lvPPA.
Age Time since onset (years) Deletions Insertions Substitutions Transpositions
Case 1 68 1, 5 5 2 1 0
Case 2 72 4 0 0 1 0
Case 3 63 1 0 1 4 0
Case 4 61 3 0 0 0 0
Case 5 79 5 1 0 0 0
Case 6 65 2 1 0 0 0
Case 7 77 2 0 1 3 0
Case 8 76 10 0 1 3 0
Case 9 70 2 0 0 0 0
Number of cases presenting with a given error type (%) 3 (33%) 4 (44%) 5 (55%) 0 (0%)
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semantic 60-s verbal ﬂuency trials. If the patient was
administered two ﬂuency tasks, the mean score from these
two tasks was used for further analyses. Mini-Mental State
Examination was administered in all AD and MCI patients.
2.3. Statistical analysis
Normality of distribution was assessed with Shapiro–Wilk test
and homogeneity of variance was veriﬁed with the use of
Levene's test. The differences between three groups were
analyzed with the use of one-way ANOVA (with Tukey's post
hoc test) for variables that were normally distributed or with H
Kruskal–Wallis test with post hoc comparisons for non-
normally distributed variables. The differences between two
groups were analyzed with the use of U Mann–Whitney test.
The differences in distribution of qualitative variables were
analyzed by chi-square test. The statistical signiﬁcance level
was set at 0.05 for all analyses.
3. Results
Most writing parameters were comparable in lvPPA, AD and
MCI (see Table 2). In terms of lexical content patients with
lvPPA used more verbs than patients with AD or MCI. Among
spelling errors, letter insertion errors were present only in
individuals with lvPPA (see Table 3). In lvPPA substitution
errors were most common, followed by insertion and deletion
errors.
Patients with lvPPA wrote more sentences than patients
with AD. Punctuation errors and omission of diacritical signs
were quite common in all patient groups. All but one patient
produced the whole writing sample in cursive. One patient
with lvPPA wrote in upper-case print. In none of the
participants inappropriate mixing of case form was present.
4. Discussion
Our study shows that written description of a complex pictures
is not as good as verbal ﬂuency tasks or confrontation naming
task at detecting word-ﬁnding or phonological problems, being
the hallmark of lvPPA [6]. On the one hand, this can be
interpreted as an evidence of lack of sensitivity of written
picture description to word-ﬁnding and phonological im-
pairment. On the other hand, these results can be viewed as anindirect sign of possible common underlying pathology in
lvPPA, MCI and AD groups.
Obviously, word-ﬁnding difﬁculties are more likely to
manifest during a confrontation naming task than in a written
picture description, as in the latter context the patient may use
the words that come to his/her mind and unless a major
element of the picture remains unnamed, anomia does not
have to be clearly manifested. Similarly, written picture
description is less challenging phonologically than writing
to dictation as the patient may choose to write only short
words with simple phonological structure that he/she is able
to spell correctly. In our study written picture description was
chosen instead of writing to dictation as it is not dependent on
preserved hearing and examiner's articulatory proﬁciency.
Thus, as it is less likely to be biased by these confounding
factors such assessment is more practical for clinicians that
are not speech and language therapists. Unfortunately,
written picture description, similarly as oral and written
confrontation naming, may be compromised because of visual
problems.
Our ﬁndings can also be regarded as an indirect hint of
common underlying pathology in all three patient groups. The
majority of patients with MCI presented with amnestic MCI,
that is likely to be MCI due to AD. Logopenic variant of PPA is
very often referred to as linguistic/language/aphasic variant of
AD [4,33]. However, not all patients with a clinical diagnosis
of lvPPA have positive beta-amyloid imaging [14] and only half
of them have AD pathology in neuropathological examination
[34]. Thus, at least some of patients from lvPPA group may
suffer from focal presentation of AD [4].
Despite the overall similarity of writing performance in
lvPPA, AD and MCI, observed in our study, few aspects
differentiated between the groups. Patients with lvPPA used
more verbs in their descriptions than individuals with AD. This
higher use of verbs may be due to anomia in lvPPA. The higher
percentage of verbs was observed in descriptive speech of
patients with lvPPA relative to controls [35] and patients with
nfvPPA [36]. While patients with nfvPPA present with more
impaired verb naming than noun naming, this effect is not
present in lvPPA [37].
Spelling deﬁcit may be one of the earliest symptoms of
lvPPA [38]. Patient recently diagnosed by one of the authors
(AB) provided such information spontaneously during
interview, stating ‘‘I can't repeat words and omit letters
while writing’’. Usually, in lvPPA both phonologically plausi-
ble and non-phonologically plausible errors are present
[24,39–42].
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between the groups, while letter deletions and substitutions
appeared in all groups with low but comparable frequency.
Thus, it is likely that some spelling deﬁcits were present in all
groups. It was demonstrated that in AD non-phonologically
plausible letter errors are more frequent in writing nonwords
that regular words [43]. As mentioned before, written picture
description is less likely to provoke non-phonologically
plausible errors than writing irregular words or non-words
to dictation. As evidenced by lack of transpositions in lvPPA
and AD, this type of error is unlikely to reﬂect phonological
problems. Transposition errors, typical for graphemic buffer
disorder, are sequence errors more typical for non-ﬂuent
aphasia, that may be related with visuospatial sketchpad [39].
Allographic agraphia was absent in all patient groups. As it
is more likely to appear in severe than in mild AD [44], lack of
allographic errors in our AD sample comprising patients with
mild AD is in accordance with the literature. Writing
assessment can complement neuropsychological assessment
in the differential diagnosis of lvPPA, AD and MCI. It seems to
be more convenient and less stressful for patients with anomia
than oral picture description. However, written picture
description cannot serve as a stand-alone tool to differentiate
between lvPPA and AD. Verbal ﬂuency and confrontation
naming tasks are more sensitive to anomia than written
picture description.
5. Conclusions
Descriptive writing assessment is helpful in the differential
diagnosis of lvPPA, AD and MCI. Its results may only
complement neuropsychological assessment and serve as a
secondary tool in the diagnostic process. Spelling errors were
present in all patient groups. Only letter insertion errors
differentiated lvPPA from AD and MCI, as insertions were
present in 44% of patients with lvPPA and absent in AD and
MCI.
Conﬂict of interest
None declared.
Acknowledgments and ﬁnancial support
We are very grateful to all our colleagues, who referred
patients to us, especially to: Małgorzata Chodakowska-
Żebrowska M.D., Maria Styczyńska M.D., Ph.D. and Ewa
Narożańska, M.D., Ph.D. During the preparation of the
manuscript EJS received a scholarship from Polish Ministry
of Science and Higher Education for young researchers.
Ethics
The work described in this article has been carried out in
accordance with The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments involvinghumans; Uniform Requirements for manuscripts submitted to
Biomedical journals.
r e f e r e n c e s
[1] Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A,
Mendez M, Cappa SF, et al. Classiﬁcation of primary
progressive aphasia and its variants. Neurology 2011;76
(11):1006–14.
[2] Sitek EJ, Barczak A, Narożańska E, Harciarek M, Brockhuis B,
Dubaniewicz-Wybieralska M, et al. Primary progressive
aphasia – the use of new diagnostic criteria in clinical
practice. Pol Prz Neurol 2014;10(1):23–33 [in Polish].
[3] Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM,
Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in
three variants of primary progressive aphasia. Ann Neurol
2004;55(3):335–46.
[4] Stopford CL, Snowden JS, Thompson JC, Neary D. Variability
in cognitive presentation of Alzheimer's disease. Cortex
2008;44(2):185–95.
[5] Leyton CE, Hodges JR. Towards a clearer deﬁnition of
logopenic progressive aphasia. Curr Neurol Neurosci Rep
2013;13(11):396.
[6] Leyton CE, Ballard KJ, Piguet O, Hodges JR. Phonologic errors
as a clinical marker of the logopenic variant of PPA.
Neurology 2014;82(18):1620–7.
[7] Teichmann M, Kas A, Boutet C, Ferrieux S, Nogues M, Samri
D, et al. Deciphering logopenic primary progressive aphasia:
a clinical, imaging and biomarker investigation. Brain
2013;136(11):3474–88.
[8] Leyton CE, Savage S, Irish M, Schubert S, Piguet O, Ballard
KJ, et al. Verbal repetition in primary progressive aphasia
and Alzheimer's disease. J Alzheimers Dis 2014;41(2):
575–85.
[9] Foxe DG, Irish M, Hodges JR, Piguet O. Verbal and
visuospatial span in logopenic progressive aphasia and
Alzheimer's disease. J Int Neuropsychol Soc 2013;19(3):
247–53.
[10] Harciarek M, Sitek EJ, Kertesz A. The patterns of progression
in primary progressive aphasia – implications for
assessment and management. Aphasiology 2014;28
(8–9):964–80.
[11] Gaweł M, Domitrz I. Primary progressive aphasia: primary
nonﬂuent aphasia or logopenic aphasia. A case report.
Neurol Neurochir Pol 2009;43(4):382–7.
[12] Sitek EJ, Narożańska E, Brockhuis B, Muraszko-Klaudel A,
Lass P, Harciarek M, et al. Neuroimaging in the differential
diagnosis of primary progressive aphasia – illustrative case
series in the light of new diagnostic criteria. Pol J Radiol
2014;79(8):251–8.
[13] Ikeda M, Tashiro Y, Takai E, Kurose S, Fugami N, Tsuda K,
et al. CSF levels of Ab1-38/Ab1-40/Ab1-42 and (11)C PiB-PET
studies in three clinical variants of primary progressive
aphasia and Alzheimer's disease. Amyloid 2014;21(4):
238–45.
[14] Whitwell JL, Duffy JR, Strand EA, Machulda MM, Senjem ML,
Schwarz CG, et al. Clinical and neuroimaging biomarkers of
amyloid-negative logopenic primary progressive aphasia.
Brain Lang 2015;142(3):45–53.
[15] Leyton CE, Hsieh S, Mioshi E, Hodges JR. Cognitive decline in
logopenic aphasia: more than losing words. Neurology
2013;80(10):897–903.
[16] Hsieh S, Hodges JR, Leyton CE, Mioshi E. Longitudinal
changes in primary progressive aphasias: differences in
cognitive and dementia staging measures. Dement Geriatr
Cogn Disord 2012;34(2):135–41.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 2 3 9 – 2 4 4244[17] Jang J, Cushing N, Clemson L, Hodges JR, Mioshi E. Activities
of daily living in progressive non-ﬂuent aphasia, logopenic
progressive aphasia and Alzheimer's disease. Dement
Geriatr Cogn Disord 2012;33(5):354–60.
[18] Mesulam M, Wieneke C, Rogalski E, Cobia D, Thompson C,
Weintraub S. Quantitative template for subtyping primary
progressive aphasia. Arch Neurol 2009;66(12):1545–51.
[19] Leyton CE, Villemagne VL, Savage S, Pike KE, Ballard KJ,
Piguet O, et al. Subtypes of progressive aphasia: application
of the International Consensus Criteria and validation
using b-amyloid imaging. Brain 2011;134(10):3030–43.
[20] Savage S, Hsieh S, Leslie F, Foxe D, Piguet O, Hodges JR.
Distinguishing subtypes in primary progressive aphasia:
application of the Sydney language battery. Dement Geriatr
Cogn Disord 2013;35(3–4):208–18.
[21] Magnin E, Chopard G, Ferreira S, Sylvestre G, Dariel E, Ryff I,
et al. Initial neuropsychological proﬁle of a series of 20
patients with logopenic variant of primary progressive
aphasia. J Alzheimers Dis 2013;36(4):799–808.
[22] Neils-Strunjas J, Groves-Wright K, Mashima P, Harnish S.
Dysgraphia in Alzheimer's disease: a review for clinical
and research purposes. J Speech Lang Hear Res 2006;49
(6):1313–30.
[23] Croisile B. Agraphia in Alzheimer's disease. Dement Geriatr
Cogn Disord 1999;10(3):226–30.
[24] Sepelyak K, Crinion J, Molitoris J, Epstein-Peterson Z, Bann
M, Davis C, et al. Patterns of breakdown in spelling in
primary progressive aphasia. Cortex 2011;47(3):342–52.
[25] Graham N. Dysgraphia in primary progressive aphasia:
characterisation of impairments and therapy options.
Aphasiology 2014;28(8–9):1092–111.
[26] McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr
CR, Kawas CH, et al. The diagnosis of dementia due to
Alzheimer's disease: recommendations from the National
Institute on Aging-Alzheimer's Association workgroups on
diagnostic guidelines for Alzheimer's disease. Alzheimers
Dement 2011;7(3):263–9.
[27] Morris JC. The Clinical Dementia Rating (CDR): current
vision and scoring rules. Neurology 1993;43(11):2412–4.
[28] Petersen RC. Mild cognitive impairment. N Engl J Med
2011;364(23):2227–34.
[29] Goodglass H, Kaplan E, Barresi B. Boston diagnostic aphasia
examination – third edition (BDAE-3). Austin, TX, USA: PRO-
ED; 2000.
[30] Enderby P, Crow E. Frenchay Aphasia Screening Test:
validity and comparability. Disabil Rehabil 1996;18(5):
238–40.
[31] Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN,
Warren JD. Word-ﬁnding difﬁculty: a clinical analysis of the
progressive aphasias. Brain 2008;131(1):8–38.[32] Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation
of the Addenbrooke's Cognitive Examination III in
frontotemporal dementia and Alzheimer's disease. Dement
Geriatr Cogn Disord 2013;36(3–4):242–50.
[33] Snowden JS, Thompson JC, Stopford CL, Richardson AM,
Gerhard A, Neary D, et al. The clinical diagnosis of early-
onset dementias: diagnostic accuracy and
clinicopathological relationships. Brain 2011;134(9):2478–92.
[34] Harris JM, Gall C, Thompson JC, Richardson AM, Neary D, du
Plessis D, et al. Classiﬁcation and pathology of primary
progressive aphasia. Neurology 2013;81(21):1832–9.
[35] Wilson SM, Henry ML, Besbris M, Ogar JM, Dronkers NF,
Jarrold W, et al. Connected speech production in three
variants of primary progressive aphasia. Brain 2010;133
(7):2069–88.
[36] Thompson CK, Meltzer-Asscher A, Cho S, Lee J, Wieneke C,
Weintraub S, et al. Syntactic and morphosyntactic
processing in stroke-induced and primary progressive
aphasia. Behav Neurol 2013;26(1–2):35–54.
[37] Thompson CK, Lukic S, King MC, Mesulam MM, Weintraub
S. Verb and noun deﬁcits in stroke-induced and primary
progressive aphasia: The Northwestern Naming Battery.
Aphasiology 2012;26(5):632–55.
[38] Rapp B, Glucroft B. The beneﬁts and protective effects of
behavioural treatment for dysgraphia in a case of primary
progressive aphasia. Aphasiology 2009;23(2):236–65.
[39] Faria AV, Crinion J, Tsapkini K, Newhart M, Davis C, Cooley
S, et al. Patterns of dysgraphia in primary progressive
aphasia compared to post-stroke aphasia. Behav Neurol
2013;26(1–2):21–34. http://dx.doi.org/10.3233/BEN-2012-
110237
[40] Henry ML, Beeson PM, Alexander GE, Rapcsak SZ. Written
language impairments in primary progressive aphasia: a
reﬂection of damage to central semantic and phonological
processes. J Cogn Neurosci 2012;24(2):261–75.
[41] Shim H, Hurley RS, Rogalski E, Mesulam MM. Anatomic,
clinical, and neuropsychological correlates of spelling
errors in primary progressive aphasia. Neuropsychologia
2012;50(8):1929–35.
[42] Tsapkini K, Hillis AE. Spelling intervention in post-stroke
aphasia and primary progressive aphasia. Behav Neurol
2013;26(1–2):55–66. http://dx.doi.org/10.3233/BEN-2012-
110240
[43] Lambert J, Viader F, Eustache F, Morin P. Contribution to
peripheral agraphia. . . a case of post-allographic
impairment? Cogn Neuropsychol 1994;11(1):35–55.
[44] Silveri MC, Ciccarelli N. Naming of grammatical classes in
frontotemporal dementias: linguistic and non linguistic
factors contribute to noun–verb dissociation. Behav Neurol
2007;18(4):197–206.
